Clinical Trial Update: The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors

View source ↗

Summary

A clinical trial update reports safety and efficacy data for sunitinib in Chinese patients with progressive, advanced or metastatic well-differentiated unresect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Pancreatic Neuroendocrine Tumors | Status: COMPLETED | Results posted: 2024-06-20